DUBLIN, August 1, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/63jhhs/global_deep_brain) has announced the addition of the "Global Deep Brain Stimulator Market 2012-2016" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
One of the key factors contributing to this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, the high cost of deep brain stimulation treatment could pose a challenge to the growth of this market.
The key vendors dominating this space are Boston Scientific Corp., Medtronic Inc., and St. Jude Medical Inc.
The other vendors mentioned in the report are Advanced Neuromodulation Systems Inc., BioControl Medical Ltd., Carl Zeiss Inc., cerboMed GmbH, Codman &Shurtleff Inc., Cyberonics Inc., DePuy Inc., EndoStim Inc., EnteroMedics Inc., Neuronetics Inc., NeuroPace Inc., Neuros Medical Inc., NeuroSigma Inc., NeuroVista Corp., Nevro Corp., and The Magstim Company Ltd.
Commenting on the report, an analyst from the healthcare team said: "There is a general perception that DBS treatments are risky since they involve surgery to implant electrodes in the brain. Hence, less invasive and non-invasive DBS treatments are gaining greater acceptance from doctors and surgeons in the Healthcare industry. New lines of research in the R and D sector are enabling surgeons and healthcare specialists to carry out more selective stimulation. For instance, selective stimulation is used with respect to the innervation of the urinary bladder at peripheral sites (such as pudendal nerve stimulation) with the use of less invasive devices such as Bion and other implantable devices. Thus, the adoption of alternative treatments that are less invasive is seen to be an emerging trend during the forecast period."
According to the report, one of the key drivers in this market is that DBS therapy is considered to be the standard form of care for many diseases and conditions such as epilepsy, depression, stroke, anxiety disorders, and Parkinson's disease. Hence, this market is expected to grow at a rapid pace and achieve a similar market size to the Global Cardiac Devices market.
For more information visit http://www.researchandmarkets.com/research/63jhhs/global_deep_brain
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SOURCE Research and Markets